Molecular Diagnostics: Technologies and Global Markets 2019-2021 & 2026 by Technology, Application & Region

News provided by

May 06, 2022, 12:30 ET

DUBLIN, May 6, 2022 /PRNewswire/ -- The "Molecular Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The goal of all DNA-based diagnostic assays is similar, but several different technologies can be employed. The report analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents and factors affecting the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also examined.

Key molecular diagnostic technologies and products are analyzed to determine present and future market status, and growth is forecast from 2021 to 2026. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces are also provided.

Report Includes

60 tables
An overview of the global market and technologies for molecular diagnostics
Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region
Information about food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of novel therapeutic products and their approvals
Discussion on related issues, government regulations, and reimbursement through insurance, patient confidentiality and other legal ramifications
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Company profiles of major players, including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc

Medical device companies, both industry giants and startups, are significantly investing in research and development (R&D) to develop innovative diagnostic products that can manage a host of medical conditions, including obesity, sleep apnea, diabetes, chronic obstructive pulmonary disease (COPD), asthma and cardiac diseases, as well as disability rehabilitation and the monitoring of progressive nervous system disorders, such as Parkinson's disease.

The increasing prevalence of diseases requiring round-the-clockmonitoring is an important driverof the market, and it is expected to significantly contribute to the industry's double-digit growth, especially considering the increase in the global geriatric population. Technological advancements are also promoting the adoption of many diagnostic products.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview

Introduction to Genomic Diagnostics
Expression Profiling and Disease
Expression Profiling and Infectious Disease
Dna Sequencing for Genotyping and Diagnosis
Clinical Pharmacology
Mutation Detection and Genotyping for Specific Genes
Identification of New Disease Genes

Chapter 4 Impact of the Covid-19 Pandemic

Introduction
Impact of Covid-19 on Market
Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

Market Drivers
High Incidences of Infectious Diseases
Increasing Incidences of Chronic Disease
Increasing Research and Development Budget
Increasing Healthcare Expenditures
Restraints and Challenges
Stringent Regulatory Framework
High R&D and Marketing Costs
Opportunities
Point-Of Care Tests That Minimize Dependency on Lab Testing
Discovery of New Biomarkers and Advances in Molecular Techniques

Chapter 6 Market Breakdown by Technology

Microarrays
Description
Microfluidic Devices
Market Size and Forecast
PCR
Market Size and Forecast
In Situ Hybridization
Labeling Techniques
In Situ Hybridization Applications
Fiber Fish
Her2 Fish Testing
Market Size and Forecast
Others
Trend Toward Single-Cell Measurements
Market Size and Forecast

Chapter 7 Molecular Diagnostics by Application

Infectious Diseases
Market Size and Forecast
Oncology
Leukemias
Chronic Myeloid Leukemia
Genetic Marker of Chronic Myeloid Leukemia
Market Size and Forecast
Pre- and Post-Natal Screening
Carrier Screening
Prenatal Diagnostic Testing
Amniocentesis
Chorionic Villus Sampling
Genetic Counseling
Preimplantation Diagnosis
Newborn Screening
Market Size and Forecast
Identity and Paternity
Paternity Testing
Technology
Accreditation
Legal Issues
Veterinary Identity Testing
Market Size and Forecast
Others
Market Size and Forecast

Chapter 8 Market Breakdown by Region

Global Molecular Diagnostic Market by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Chapter 9 Regulations and Finance

Overview
Europe
U.S.
Japan
Insurance
Food and Drug Administration Guidelines
Internal Standards for DNA Diagnostics
Minimum Information About a Microarray
Experiment: Miame 2.0
Microarray Quality Control Project
Clinical Laboratory Improvement Amendments
Personalized Medicines and Companion Diagnostics
FDA Guidelines for in Vitro Companion Diagnostics
Definition and Use of An IVD Companion Diagnostic Device
Review and Approval of IVD Companion Diagnostic Devices and Therapeutic Products
Novel Therapeutic Products
Approval of a Therapeutic Product Without An Approved Ivd Companion Diagnostic Device
General Policies
FDA Approved Companion Diagnostics
Nucleic Acid-Based Tests
Pharmacogenomics Research Network